OSOBENNOSTI SAKhAROSNIZhAYuShchEY TERAPII VO VREMYa BEREMENNOSTI
- Авторлар: Arbatskaya N.Y.1
-
Мекемелер:
- Шығарылым: № 5 (2014)
- Беттер: 94-99
- Бөлім: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/286761
- ID: 286761
Дәйексөз келтіру
Ашық рұқсат
Рұқсат берілді
Аннотация
Diabetes mellitus (DM) is associated with a high risk of prenatal, obstetric and vascular complications in women. For the improvement of pregnancy outcomes, DM women need to have rigid limits of glycemic control. The target blood glucose levels during pregnancy can be achieved only through an integrated approach to treatment, which includes multiple self-control of blood glucose level and self-control of ketonuria, functional insulin therapy, the use of insulin pump therapy, split meals with the exception of carbohydrates with a high glycemic index and rich in dietary fiber, and graduated exercises.
Негізгі сөздер
Толық мәтін
Әдебиет тізімі
- Дедов И.И., Шестакова М.В. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. М., 2013. 120 c.
- Арбатская H.Ю. Эффективность программы обучения и наблюдения в комплексной терапии беременных с сахарным диабетом 1 типа. Дис.. канд. мед. наук. М., 2004. 129 с.
- Коваленко Т.С. Беременность и инсулинзависимый сахарный диабет: прогностические критерии гестоза и исхода для плода. Дисс.. канд. мед. наук. М., 2000. 24 с.
- Ланцева О.Е. Функциональная инсулинотерапия инсулинозависимого сахарного диабета во время беременности. Дисс.. канд. мед. наук. СПб., 1999. 115 с.
- Федоров М.В., Краснопольский В.И., Петрухин В.А. Сахарный диабет, беременность и диабетическая фетопатия. М., 2001. С. 59-199.
- American Diabetes Association. Medical management of pregnancy complicated by diabetes. 2000. 175 p.
- Guerin A., Nisenbaum R., Kay J.G. Use of maternal GHb concentration to estimate the risk of congenital anomalies in the offspring of women with prepregnancy diabetes. Diabetes Care. 2007; 30: 1920-25.
- Johnstone F.D., Mao J.-N., Steel J.M., Prescott R.J., Hume R. Factors effecting fetal weight distribution in women with type 1 diabetes.Br. J. Obstet. Gyn. 2000; 107: 1001-06.
- Haworka V., Pumprla J., Gabriel M., et al. Normalization of pregnancy outcome in pregestational diabetes through functional insulin treatment and modular outpatients education adapted for pregnancy. Diabet. Med. 2001; 18: 956-72.
- Hod M. Glycemic thresholds in real life. EASD 43rd annual meeting. 2007. 1235 p.
- Hod M., Jovanovic L., Di Renzo G.C., de Leiva A., Langer O. Textbook of diabetes and pregnancy. UK, 2003.
- Hod M., Visser G.H.A., Damm P., et al. Safety and perinatal outcome in pregnancy: a randomized trial comparing insulin aspart with human insulin in 322 subjects with type 1 diabetes. Diabetes. 2006; 53(1): 417.
- Kitzmiller J.L., Block J.M., Brown F.M., et al. Management of Preexisting Diabetes and Pregnancy. Alexandria, Virginia, American Diabetes Association, 2008.
- Leahy J.L., Cefal W.T. Insulin Therapy. 2002.
- Mondestin M.A.J., Ananth C.V., Smulian J.C., Vintzileos A.M. Birth weight and fetal death in the United States: the effect of maternal diabetes during pregnancy. Am. J. Obstet. Gyn. 2002; 187: 922-26.
- Stotland N.E., Caughey А.В., Breed E.M., Escobar G.J. Risk factors and obstetric complications associated with macrosomia. Int. J. Gyn. Obstet. 2004; 87: 220-26.
- Wender-Ozegowska E., Wroblewska K., Zawiejska A., et al. Threshold values of maternal blood glucose in early diabetic pregnancy -predictor of fetal malformations. Acta Obstet. Gynecol. Scand. 2005; 84: 17-25.
Қосымша файлдар
